Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

The investigational oral therapy KTX-1001, also known as gintemetostat, is catching interest as a potential treatment for a subgroup of patients with multiple myeloma, as an expert explained in a ...

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...

Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure.

(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...

Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by ...

Data-driven analysis shows outpatient stem-cell mobilisation can reduce hospital bed use while maintaining safety, supported ...

Nonresponse to bridging therapy and high lymphocyte count were predictive of parkinsonism and nonrelapse mortality (NRM) after treatment with ciltacabtagene autoleucel (cilta-cel; Carvykti) in ...

Facing a cancer diagnosis requires immense strength, especially under the public eye. These brave television stars shared ...

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...

The late-night/early-morning spot for Cubs fans asks if Kyle Tucker or Alex Bregman give them a better chance to win.

At a FICCI Flo Ahmedabad chapter event where she came as speaker, Ray spoke about life after she was diagnosed with multiple ...